Major Step Forward in Improving Men’s Health
Media Release
11 June 2012
Revolutionary Electronic Tool for GPs a Major Step
Forward in Improving Men’s Health
To coincide with the launch of Men’s Health Week 2012, Comprehensive Care Ltd in association with Waitemata PHO and the Prostate Cancer Foundation of NZ, have signed a contract to develop a new electronic decision support tool for men.
This is a New Zealand first and a major step forward in improving men’s health in New Zealand.
The main aim of the tool is to empower both doctors and patients to confidently address a diverse range of men’s health issues, with a particular focus on prostate diseases, both benign and cancerous. It will also lead to important age-related IT supported screening tests such as diabetes checks and heart risk analysis.
The prototype was developed by Comprehensive Care General Practitioner, Dr Prakash Appanna, whose practice is based in Birkenhead, Auckland.
“I was concerned about the confusion
being created with messages to the public and GPs about PSA
(Prostate Specific Antigen) testing and prostate cancer
screening and its effect on our doctors, especially the
newer entrants into our profession. The debate about PSA
screening was clouding the key issues we should be
addressing.”
“I therefore set
about developing a tool that would put the focus where it
should be, on men’s health and quality of life.”
“Urological problems are an
important part that is often ignored. Lack of sleep from
prostatism is very rarely addressed, and is accepted by
patients as being ’normal’ as you get older, yet
treating Benign Prostate Hyperplasia is easy using a
user-friendly decision aid,” says Dr Appanna.
Dr Lannes Johnson, Clinical Director of Waitemata
PHO, and a long-standing advocate for male health, is
leading the project.
“The new tool will provide
a more evidence-based guideline approach that could be built
into the practice management systems of every New Zealand
practice. It will reduce unnecessary and possibly harmful
investigations or treatment and provide early diagnosis of
prostate conditions.”
“It will
also help doctors and their patients to make the right
decisions, at the right time, in regards to testing
procedures, as well as provide immediate personalised
information for the patient that can be given to them,
instead of a generic leaflet about their condition.”
says Dr Johnson.
Dr Johnson thanks the Prostate
Cancer Foundation of New Zealand in taking an active role in
bringing this new tool into fruition.
He anticipates
beta testing the tool later this year and offering it to New
Zealand practices in 2013.
Prostate Cancer Foundation of New Zealand CEO, Keith Beck, says the project is being funded through its annual research grant fund.
“PCFNZ sees the Comprehensive Care software project as a major step forward in the dissemination of up to date prostatic information to both doctors and patients and a project PCFNZ had to be involved in,” says Mr. Beck.
ENDS
*